title: High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
authors.forename: J
authors.initials: J
authors.lastname: Barua
authors.forename: I
authors.initials: I
authors.lastname: Campbell I
authors.forename: O
authors.initials: O
authors.lastname: Cole
authors.forename: D
authors.initials: D
authors.lastname: Harris
authors.forename: A
authors.initials: A
authors.lastname: Kaisary
authors.forename: T
authors.initials: T
authors.lastname: Larner
authors.forename: P
authors.initials: P
authors.lastname: Miller
authors.forename: R
authors.initials: R
authors.lastname: Nigam
authors.forename: F
authors.initials: F
authors.lastname: Mumtaz
authors.forename: R
authors.initials: R
authors.lastname: Thilagarajah
authors.forename: A
authors.initials: A
authors.lastname: Thompson
authors.forename: S
authors.initials: S
authors.lastname: Brown
mesh_terms: D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000628:therapy*; D012003:Rectal Fistula / Q000209:etiology; D016879:Salvage Therapy / Q000009:adverse effects*; D013997:Time Factors; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000009:adverse effects*; D014525:Urethral Stricture / Q000209:etiology; D016055:Urinary Retention / Q000209:etiology
chemical_list: D017430:Prostate-Specific Antigen